Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes
Your provider will review your medical history, overall health status, and wellness goals before determining whether compounded semaglutide may be appropriate within your care plan
Treatments rely on science, not trends, matched closely to personal skin issues
It is a potent antioxidant, which repairs damaged cells, detoxifies the liver, boosts the immune system, and assists in the metabolism of toxins
Destruction and reformation of an iron-sulfur cluster during catalysis by lipoyl synthase
Pregnancy and breastfeeding require avoiding both compounds entirely